|
1
|
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells.
|
Arterioscler Thromb Vasc Biol
|
2008
|
1.79
|
|
2
|
TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
|
Circulation
|
2003
|
1.71
|
|
3
|
L-carnitine is an osmotic agent suitable for peritoneal dialysis.
|
Kidney Int
|
2011
|
1.45
|
|
4
|
Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1.
|
Mol Endocrinol
|
2009
|
1.18
|
|
5
|
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells.
|
Circ Res
|
2003
|
1.17
|
|
6
|
G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.
|
Circulation
|
2004
|
1.09
|
|
7
|
The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases.
|
Endocr Rev
|
2012
|
1.04
|
|
8
|
Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.
|
Circ Res
|
2009
|
1.04
|
|
9
|
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction.
|
Am J Pathol
|
2006
|
1.00
|
|
10
|
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response.
|
FASEB J
|
2010
|
0.93
|
|
11
|
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture.
|
J Cell Biochem
|
2006
|
0.90
|
|
12
|
Wnt signaling behaves as a "master regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells.
|
Stem Cell Rev
|
2013
|
0.90
|
|
13
|
β-Carotene and lycopene affect endothelial response to TNF-α reducing nitro-oxidative stress and interaction with monocytes.
|
Mol Nutr Food Res
|
2011
|
0.88
|
|
14
|
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells.
|
Arterioscler Thromb Vasc Biol
|
2009
|
0.88
|
|
15
|
High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia?
|
Cardiovasc Res
|
2010
|
0.87
|
|
16
|
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.
|
Atherosclerosis
|
2011
|
0.86
|
|
17
|
Increased iNOS activity in vascular smooth muscle cells from diabetic rats: potential role of Ca(2+)/calmodulin-dependent protein kinase II delta 2 (CaMKIIδ(2)).
|
Atherosclerosis
|
2012
|
0.86
|
|
18
|
The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells.
|
Cardiovasc Res
|
2010
|
0.84
|
|
19
|
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
|
Diabetes Metab Res Rev
|
2008
|
0.83
|
|
20
|
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.
|
Atherosclerosis
|
2012
|
0.83
|
|
21
|
Possible role for nitric oxide dysregulation in critical illness myopathy.
|
Muscle Nerve
|
2008
|
0.83
|
|
22
|
Calcimimetic R-568 and its enantiomer S-568 increase nitric oxide release in human endothelial cells.
|
PLoS One
|
2012
|
0.81
|
|
23
|
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.
|
PLoS One
|
2012
|
0.81
|
|
24
|
Calcium sensing receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: correlation with osteogenic differentiation.
|
Stem Cells Dev
|
2014
|
0.81
|
|
25
|
Adherence of uremic erythrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression.
|
Kidney Int
|
2005
|
0.80
|
|
26
|
State-of-the-art on basic and applied stem cell therapy; Stem Cell Research Italy-International Society for Cellular Therapy Europe, Joint Meeting, Montesilvano (PE)-Italy, June 10-12, 2011.
|
Stem Cells Dev
|
2011
|
0.80
|
|
27
|
Plasma protein carbonylation in chronic uremia.
|
J Nephrol
|
2011
|
0.78
|
|
28
|
Calcium sensing receptor expression in ovine amniotic fluid mesenchymal stem cells and the potential role of R-568 during osteogenic differentiation.
|
PLoS One
|
2013
|
0.78
|
|
29
|
Trisomy 21 mid-trimester amniotic fluid induced pluripotent stem cells maintain genetic signatures during reprogramming: implications for disease modeling and cryobanking.
|
Cell Reprogram
|
2014
|
0.78
|
|
30
|
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro.
|
J Cell Physiol
|
2007
|
0.77
|
|
31
|
Insulin resistance affects gene expression in endothelium.
|
Arterioscler Thromb Vasc Biol
|
2008
|
0.77
|
|
32
|
Calcitonin-induced effects on amniotic fluid-derived mesenchymal stem cells.
|
Cell Physiol Biochem
|
2015
|
0.76
|
|
33
|
C-reactive protein: a potential new molecular link between inflammation, thrombosis and vascular cell proliferation?
|
Cardiovasc Res
|
2005
|
0.75
|
|
34
|
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors.
|
J Sep Sci
|
2014
|
0.75
|
|
35
|
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia].
|
G Ital Nefrol
|
2017
|
0.75
|